SEARCH

SEARCH BY CITATION

REFERENCES

  • Bennett LM. 1999. Breast cancer: Genetic predisposition and exposure to radiation. Mol Carcinog 26: 143149.
  • Bennett LM, McAllister KA, Malphurs J, Ward T, Collins NK, Seely JC, Gowen LC, Koller BH, Davis BJ, Wiseman RW. 2000. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland ovarian phenotypes in response to diethylstilbestrol. Cancer Res 60: 34613469.
  • Bennett LM, McAllister KA, Ward T, Malphurs J, Collins NK, Seely JC, Davis BJ, Wiseman RW. 2001. Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency. Toxicol Pathol 29: 117125.
  • Bucher JR. 1998. Update on National Toxicology Program (NTP) assays with genetically altered or “transgenic” mice. Environ Health Perspect 106: 619621.
  • Charpin C, Bonnier P, Garcia S, Andrac L, Crebassa B, Dorel M, Lavaut MN, Allasia C. 1999. E-cadherin and β-catenin expression in breast medullary carcinomas. Int J Oncol 15: 258292.
  • Colton T, Greenberg ER, Noller K, Resseguid L, Van Bennekom C, Heeren T, Zhang Y. 1993. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. JAMA 269: 20962100.
  • Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. 1999. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 18: 47264733.
  • Drinkwater NR, Bennett LM. 1990. Genetic control of carcinogenesis in experimental animals. In: ItoN, editor. Modification of tumor development in rodents. Basel: Karger. p 120.
  • Dunnick JK, Elwell MR, Huff J, Barrett JC. 1995. Chemically-induced mammary-gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis 16: 173179.
  • Eastin WC, Haseman JK, Mahler JF, Bucher JR. 1998. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol Pathol 26: 461473.
  • Fournier D, Erdman J Jr, Gordon G. 1998. Soy, its components, and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiol Biomarkers Prev 7: 10551065.
  • French JE, Saulnier M. 2000. Benzene leukemogenesis: an environmental carcinogen-induced tissue-specific model of neoplasia using genetically altered mouse models. J Toxicol Environ Health 61A: 377379.
  • Greenman DL, Highman B, Kodell RL, Morgan KT, Norvell M. 1984. Neoplastic and nonneoplastic responses to chronic feeding of diethylstilbestrol in C3H mice. J Toxicol Environ Health 14: 551567.
  • Greenman DL, Highman B, Chen JJ, Schieferstein GJ, Norvell MJ. 1986. Influence of age on induction of mammary tumors by diethylstilbestrol in C3H/HeN mice with low murine mammary tumor virus titer. J Natl Cancer Inst 77: 891898.
  • Hofseth L, Raafat A, Osuch J, Pathak D, Slomski C, Haslam S. 1999. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84: 45594565.
  • Huff J. 1998. NTP report on carcinogens: history, concepts, procedures, processes. Eur J Oncol 3: 343355.
  • Hutchinson JN, Muller WJ. 2000. Transgenic mouse models of human breast cancer. Oncogene 19: 61306137.
  • International Agency for Research on Cancer (IARC). 1987. II. Oestrogens; nonsteroidal oestrogens (Suppl 7). Overall evaluations of carcinogenicity: an updating of IARC monographs. Lyon: IARC.
  • Jackson Laboratory. 2001. Inbred strains of mice and rats. http://www.informatics.jax.org/external/festing/search_form.cgi
  • Kasprzak KS. 1995. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 13: 411430.
  • Lan H, Kendziorski CM, Haag JD, Shepel LA, Newton MA, Gould MN. 2001. Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat. Genetics 157: 331339.
  • Ludwig T, Fisher P, Murty V, Efstratiadis A. 2001. Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice. Oncogene 20: 39373948.
  • Melnick RL, Sills RC, Portier CJ, Roycroft JH, Chou BJ, Grumbein SL, Miller RA. 1999. Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis 20: 867878.
  • Miller AC, Mog S, McKinney L, Luo L, Allen J, Xu J, Page N. 2001. Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Carcinogenesis 22: 115125.
  • National Toxicology Program (NTP). 2001. Home page. http:// ntp-server.niehs.nih.gov/
  • Norman SA, Berlin JA, Soper KA, Middendorf BF, Stolley PD. 1995. Cancer incidence in a group of workers potentially exposed to ethylene oxide. Int J Epidemiol 24: 276284.
  • NTP. 1986. Toxicology and carcinogenesis studies of C. I. basic red 9 monohydrochloride (CAS No. 569-61-9) in F344/N rats and B6C3F1 mice (feed studies). Bethesda, MD: National Institutes of Health.
  • NTP. 1991. Toxicology and carcinogenesis studies of C. I. acid red 114 (CAS No. 6459-94-5) in F344/N rats (drinking water studies). Bethesda, MD: National Institutes of Health.
  • NTP. 1996. Toxicology and carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol (FR-1138®) (CAS No. 3296-90-0) in F344/N rats and B6C3F1 mice (feed studies). Bethesda, MD: National Institutes of Health.
  • NTP. 1997. Toxicology and carcinogenesis studies of nitromethane (CAS No. 75-52-5) in F344/N rats and B6C3F1 mice (inhalation studies). Bethesda, MD: National Institutes of Health.
  • NTP. 1998. Toxicology and carcinogenesis studies of chloroprene (CAS No. 126-99-8) in F344/N rats and B6C3F1 mice (inhalation studies). Bethesda, MD: National Institutes of Health.
  • NTP. 1999. Toxicology and carcinogenesis studies of isoprene (CAS No. 78-79-5) in F344/N rats (inhalation studies). Bethesda, MD: National Institutes of Health.
  • NTP. 2000a. 9th report on carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program.
  • NTP. 2000b. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-80-7) in F344/N rats and B6C3F1 mice (inhalation studies). Bethesda, MD: National Institutes of Health.
  • NTP. 2000c. Toxicology and carcinogenesis studies of methyleugenol (CAS No. 93-15-2) in F344/N rats and B6C3F1 mice (gavage studies). Bethesda, MD: National Institutes of Health.
  • Ogoshi K, Yanagi S, Moriyama T, Arachi H. 1994. Accumulation of aluminum in cancers of the liver, stomach, duodenum and mammary glands of rats. J Trace Elem Electrolytes Health Dis 8: 2731.
  • Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King M-C, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W, Offit K. 1998. The APC I1307K allele and breast cancer risk. Nat Genet 20: 1314.
  • Russo IH, Russo J. 1998. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3: 4961.
  • Russo J, Russo IH. 1997. Toward a unified concept of mammary carcinogenesis. In: AldezCEA, editor. Etiology of breast and gynecological cancers: New York: Wiley-Liss. p 116.
  • Sala E, Warren R, McCann J, Duffy S, Luben R, Day N. 2000. Smoking and high-risk mammographic parenchymal patterns: a case-control study. Breast Cancer Res 2: 5963.
  • Shelby MD. 1990. Results of NTP-sponsored mouse cytogenetic studies on 1,3-butadiene, isoprene, and chloroprene. Environ Health Perspect 86: 7173.
  • Siegel PM, Hardy WR, Muller WJ. 2000. Mammary gland neoplasia: insights from transgenic mouse models. Bioessays 22: 554563.
  • Sills RC, Hong HL, Melnick RL, Boorman GA, Devereux TR. 1999. High frequency of codon 61 K-ras A[RIGHTWARDS ARROW]T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis 20: 657662.
  • Sims P, Grover PL. 1974. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res 20: 165274.
  • Storer RD. 2000. Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals—scientific perspective. Toxicol Lett 112/113: 557566.
  • Tennant RW, Rao GN, Russfield A, Seilkop S, Braun AG. 1993. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue. Carcinogenesis 14: 2935.
  • Tennant RW, Stasiewicz S, Mennear J, French JE, Spalding JW. 1999. Genetically altered mouse models for identifying carcinogens. IARC Sci Publ 146: 123150.
  • Valverde M, Trejo C, Rojas E. 2001. Is the capacity of lead acetate and cadmium chloride to induce genotoxic damage due to direct DNA-metal interaction? Mutagenesis 16: 265270.
  • Welch CW, Nagasawa H. 1977. Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37: 951963.
  • Xu XL, Wagner KU, Larson D, Weaver Z, Li CL, Ried T, Henningausen L, Wynshaw-Boris A, Deng CX. 1999. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 3743.
  • Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa Y, Hayashi Y, Nomura T. 1998. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106(Suppl 1): 5769.